Location History:
- Washington, DC (US) (1997 - 2003)
- Gaithersburg, MD (US) (1998 - 2012)
Company Filing History:
19 out of 676 
1 out of 4 
1 out of 3,682 
Years Active: 1997-2012
Title: Unveiling the Innovations of Robert D. Fleischmann
Introduction: Robert D. Fleischmann, based in Gaithersburg, MD, has made significant contributions to the field of biotechnology with a remarkable portfolio of 24 patents. His innovative work primarily revolves around human tumor necrosis factor receptors, which have profound implications in cancer treatment and autoimmune disease management.
Latest Patents: One of Robert's latest inventions focuses on "Human tumor necrosis factor receptor-like genes." This groundbreaking patent describes the discovery of novel receptors in the Tumor Necrosis Factor (TNF) receptor family. Specifically, the invention provides receptors that exhibit homology to the type 2 TNF receptor (TNF-RII) and includes isolated nucleic acid molecules encoding these novel receptors. The patent also covers receptor polypeptides, various vectors, and host cells along with recombinant methods for producing them.
Another key patent involves the "Human tumor necrosis factor receptor," which details a human TNF receptor and the DNA (RNA) encoding it. This invention outlines a procedure for producing the receptor using recombinant techniques. Additionally, the work includes methods for screening potential antagonists and agonists, as well as ligands for this receptor. These innovations have therapeutic applications for inhibiting tumor growth, stimulating cellular differentiation, and managing immune responses.
Career Highlights: Throughout his career, Robert D. Fleischmann has worked at Human Genome Sciences, Inc., where he applied his expertise in genetic research and receptor biology. His patents and discoveries have positioned him as a leading innovator in his field, contributing to advancements in medical science.
Collaborations: Robert has collaborated with notable professionals in the industry, including Mark D. Adams and Ying-Fei Wei. These collaborations have fostered an environment of innovation and have furthered the impact of their collective research contributions.
Conclusion: Robert D. Fleischmann's innovative work in the arena of TNF receptors showcases the power of scientific research and its potential to transform medical treatments. With his extensive patent portfolio, he continues to pave the way for new therapeutic strategies that could significantly improve patient outcomes in cancer and autoimmune diseases. His contributions exemplify the spirit of innovation that drives progress in biotechnology and medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.